Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro
- 31 March 2007
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 28 (9), 1629-1642
- https://doi.org/10.1016/j.biomaterials.2006.12.003
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast AgentInvestigative Radiology, 2006
- Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance ImagingInvestigative Radiology, 2004
- Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitroEuropean Radiology, 2004
- In Vivo Detection of Macrophages in Human Carotid AtheromaStroke, 2004
- Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cellsBlood, 2003
- Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coatingBiomaterials, 2003
- Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltrationKidney International, 2000
- Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancerJournal of Magnetic Resonance Imaging, 1997
- Surface properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsilMagnetic Resonance Imaging, 1995
- Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.Radiology, 1990